Group items tagged

Primary Care: Endocrinology/Rheumatology/Geriatrics/Neurology is organized by American Medical Seminars and will be held from March 11 - 14, 2024, in Florida, USA

Register for upcoming Obstetrics and Gynecology Conferences, Online CME Courses, Live Webinars, In-person Medical Conferences & Hybrid Events in 2024. Discover the future of Obstetrics and Gynecology with a wide array of well-curated CME and CE conferences, all in one place here at eMedEvents.

Register for upcoming Emergency Medicine Conferences, Online CME Courses, Live Webinars, In-person Medical Conferences & Hybrid Events in 2024. Explore all the Emergency Medicine CME/CE conferences and online courses hosted by renowned medical experts and institutions.

Register for upcoming Nursing Conferences, Online CME Courses, Live Webinars, In-person Medical Conferences & Hybrid Events in 2024.

AMS 2024: IMpu-Internal Medicine- Pulmonary online CME course is organized by American Medical Seminars, Inc. This conference has been approved for a maximum of 5 AMA PRA Category 1 Credits.

Explore Family Medicine CME Conferences, Meetings, and Online CME Courses. Register for upcoming 2023 Family Medicine Conferences & earn CME Credits. Upgrade your professional expertise by participating in the best-suited Family Medicine CME conferences and online courses and earning AMA PRA Category CME/CE credits.

Explore Internal Medicine CME Conferences, Meetings, and Online CME Courses. Register for upcoming 2023 Internal Medicine Conferences & earn CME Credits.

Find Pediatrics CME Medical Conferences 2022 Browse Upcoming Onsite/ Online Pediatrics CME Medical Conferences and Register Today

"Find Psychiatry CME Medical Conferences 2022 Browse Upcoming Onsite/ Online Psychiatry CME Medical Conferences and Register Today

The NHS is on track to miss out on savings of over a billion pounds as patents for a new lineup of 85 biologics are set to expire within the next five years, the British Generic Manufacturers Association has revealed in its new study. The government's Voluntary Scheme for Branded Medicines Pricing and Access is expected to lead to a cost of more than £1 billion for the NHS in the coming years. The BGMA research found that more than 85 biological medicines will experience loss of exclusivity during the upcoming VPAS Scheme period from 2024 to 2028. "This includes blockbuster products like the cancer medicine Keytruda and wet macular product Eylea, which together generate approximately $25 billion in global sales," BGMA said. "The molecules coming off-patent also cover other disease areas including oncology, diabetes, arthritis, and asthma." While biological medicines dominate the medicines budget, constituting the largest cost and cost growth sectors, NHS England aims to expedite biosimilar availability, yielding substantial savings and expanding patient access to vital treatments. Yet, the report found that "this is jeopardised by the influence of the VPAS Scheme".

The Pharmaceutical Services Negotiating Committee (PSNC) has commissioned Nuffield Trust and The King's Fund to develop a new vision and strategic options for community pharmacy. The report is expected to be published in early summer next year, to underpin the future strategy for the sector. It will also support negotiations between PSNC and policymakers as the current five-year Community Pharmacy Contractual Framework (CPCF) comes to an end. Those negotiations will decide what happens after April 2024, and they will be critical to the future of the sector. The development of a compelling vision and an effective strategy for community pharmacy was a key recommendation from the Pharmacy Representation Review Steering Group (RSG). It forms one of the workstreams of the Transforming Pharmacy Representation Programme (TAPR) currently being undertaken by PSNC. But it is also a project that PSNC wants to undertake anyway to help lay the foundations for those crucial upcoming negotiations.

Boots UK has agreed to grant a five per cent pay increase to its pharmacists following a collaborative agreement with the Pharmacists' Defence Association (PDA). This raise acknowledges the unique market conditions faced by pharmacists in the community pharmacy sector, Boots UK and PDA said in a joint statement on Oct. 9. According to the statement, the pay increase applies to all pharmacists within the PDA Union's bargaining unit, except for those who joined or received a pay raise after August 2023. Moreover, trainee pharmacists or those not meeting performance standards are not eligible for the raise. Additionally, pharmacists and store managers will receive a pro-rata, one-time non-consolidated payment of £750 in August 2024. This payment serves as recognition for their dedication to establishing and providing new core and advanced NHS services, particularly in light of the substantial changes anticipated in the upcoming year, the joint statement said. The services include new medicines, hypertension, contraception, and common conditions services in England, the clinical community pharmacy service in Wales, and the Pharmacy First services in Scotland and Northern Ireland.

Pharmacy owners can proceed with vaccinating patients who have already scheduled their flu vaccination appointments for September, NHS England has said. However, as announced earlier, the official rollout of the vaccination service will commence from October. Pharmacies will receive compensation for conducting appointments in the upcoming month, NHSE stated in a letter addressed to systems, community pharmacies, and general practices. "Payment for vaccinations will ordinarily only be made following the service commencement date. However, we understand that some firm commitments and appointments have already been made, so where this is the case and the patient wishes to receive flu vaccination in September, NHS England will permit payment claims to be submitted," NHSE said. Care home residents and staff will be eligible for the vaccine starting Oct. 2, while all other patients will commence receiving their vaccinations on Oct 7. This news is a significant relief for pharmacy owners, as they won't have to reschedule appointments due to NHSE's one-month service delay.

Explore Radiology CME Conferences, Meetings, and Online CME Courses. Register for upcoming 2023 Radiology Conferences & earn CME Credits.

Community Pharmacy England (CPE), the Company Chemists' Association (CCA), the Royal Pharmaceutical Society (RPS) and the National Pharmacy Association (NPA) on Tuesday (5 March) released a joint manifesto for community pharmacy in anticipation of the upcoming general election expected later this year. The manifesto has been designed for widespread use within the community pharmacy sector to facilitate engagement with political parties and parliamentary candidates. In their #VotePharmacy manifesto, the pharmacy bodies have highlighted a robust six-point plan to unleash the potential of pharmacy. Election candidates are urged to express their support in six key areas, which include: Filling the funding gap and committing to long-term sustainable funding to empower pharmacies to deliver more NHS care. Enhancing the community pharmacy workforce to ensure they can meet the evolving needs of patients.